FDA Inspection 1031471 — Immunostics, Inc.

Immunostics, Inc. — FEI 2244821

The FDA completed an inspection of Immunostics, Inc. on Nov 8, 2017 in Eatontown, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 10 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 8, 2017
Fiscal Year
2018
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Eatontown, NJ (United States)

Citations

IDCFRDescription
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
316021 CFR 820.184Lack of or inadequate DHR procedures
317221 CFR 820.198(c)Investigation of device failures
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
326221 CFR 820.250(a)Statistical techniques - Lack of or inadequate procedures
333121 CFR 820.181DMR - not or inadequately maintained
343221 CFR 820.75(b)(2)Documentation of validated process performance
54621 CFR 820.75(a)Lack of or inadequate process validation
63321 CFR 803.17(a)(3)Lack of System for Timely Submission of Reports

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.